| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 138 | 2024 | 12795 | 4.460 |
Why?
|
| Bipolar Disorder | 71 | 2025 | 5130 | 4.190 |
Why?
|
| Multifactorial Inheritance | 44 | 2025 | 1422 | 3.640 |
Why?
|
| Depressive Disorder, Major | 59 | 2025 | 4818 | 3.330 |
Why?
|
| Genetic Predisposition to Disease | 134 | 2024 | 18065 | 3.060 |
Why?
|
| Schizophrenia | 56 | 2025 | 6983 | 3.040 |
Why?
|
| Mental Disorders | 40 | 2025 | 6874 | 2.980 |
Why?
|
| Anxiety Disorders | 29 | 2023 | 2748 | 2.650 |
Why?
|
| Panic Disorder | 18 | 2015 | 613 | 2.550 |
Why?
|
| Suicide, Attempted | 22 | 2024 | 1409 | 2.480 |
Why?
|
| Polymorphism, Single Nucleotide | 118 | 2024 | 16045 | 2.350 |
Why?
|
| Electronic Health Records | 32 | 2024 | 4887 | 2.020 |
Why?
|
| Depression | 34 | 2023 | 8230 | 2.000 |
Why?
|
| Phenotype | 70 | 2024 | 16726 | 1.610 |
Why?
|
| Genomics | 24 | 2024 | 5926 | 1.600 |
Why?
|
| Psychiatry | 12 | 2018 | 1716 | 1.470 |
Why?
|
| Quantitative Trait, Heritable | 10 | 2020 | 540 | 1.390 |
Why?
|
| Military Personnel | 13 | 2024 | 1261 | 1.290 |
Why?
|
| Stress Disorders, Post-Traumatic | 26 | 2024 | 4640 | 1.230 |
Why?
|
| Depressive Disorder | 14 | 2021 | 3721 | 1.140 |
Why?
|
| Suicidal Ideation | 13 | 2024 | 1462 | 1.130 |
Why?
|
| Psychopathology | 2 | 2022 | 434 | 1.120 |
Why?
|
| Humans | 416 | 2025 | 768166 | 1.100 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 24 | 2024 | 3729 | 1.050 |
Why?
|
| Alcoholism | 8 | 2024 | 1980 | 1.020 |
Why?
|
| Antidepressive Agents | 18 | 2024 | 2913 | 0.990 |
Why?
|
| Genetic Variation | 25 | 2022 | 6611 | 0.960 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 11 | 2018 | 1988 | 0.940 |
Why?
|
| Anxiety | 23 | 2023 | 4672 | 0.940 |
Why?
|
| Brain | 41 | 2024 | 27360 | 0.940 |
Why?
|
| Cation Transport Proteins | 4 | 2023 | 326 | 0.940 |
Why?
|
| Bereavement | 3 | 2013 | 310 | 0.900 |
Why?
|
| Psychotic Disorders | 14 | 2024 | 3276 | 0.900 |
Why?
|
| Suicide | 7 | 2024 | 1606 | 0.900 |
Why?
|
| Resilience, Psychological | 6 | 2019 | 807 | 0.890 |
Why?
|
| Genotype | 55 | 2022 | 13045 | 0.880 |
Why?
|
| Personality | 6 | 2017 | 559 | 0.860 |
Why?
|
| Genetic Loci | 20 | 2024 | 2629 | 0.850 |
Why?
|
| Female | 236 | 2025 | 397192 | 0.850 |
Why?
|
| RGS Proteins | 3 | 2013 | 76 | 0.840 |
Why?
|
| Male | 211 | 2025 | 364719 | 0.800 |
Why?
|
| International Classification of Diseases | 3 | 2024 | 937 | 0.790 |
Why?
|
| Pharmacogenetics | 7 | 2014 | 683 | 0.770 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2017 | 606 | 0.770 |
Why?
|
| Risk Factors | 82 | 2025 | 74944 | 0.770 |
Why?
|
| Adult | 161 | 2025 | 223646 | 0.760 |
Why?
|
| Child Abuse | 6 | 2020 | 1091 | 0.750 |
Why?
|
| Cerebral Cortex | 13 | 2023 | 5812 | 0.750 |
Why?
|
| Calcium Channels, L-Type | 7 | 2017 | 244 | 0.750 |
Why?
|
| Cognition | 13 | 2023 | 7073 | 0.740 |
Why?
|
| Linkage Disequilibrium | 19 | 2021 | 1997 | 0.740 |
Why?
|
| Aptitude | 1 | 2019 | 43 | 0.660 |
Why?
|
| Phobic Disorders | 4 | 2008 | 441 | 0.660 |
Why?
|
| Human Development | 4 | 2021 | 122 | 0.660 |
Why?
|
| Manganese | 3 | 2022 | 394 | 0.650 |
Why?
|
| Facial Expression | 4 | 2019 | 515 | 0.640 |
Why?
|
| Risk Assessment | 18 | 2024 | 24315 | 0.620 |
Why?
|
| Glutamic Acid | 4 | 2015 | 1191 | 0.620 |
Why?
|
| Young Adult | 67 | 2025 | 60066 | 0.610 |
Why?
|
| Genome, Human | 9 | 2021 | 4446 | 0.580 |
Why?
|
| Middle Aged | 114 | 2025 | 223492 | 0.580 |
Why?
|
| Adolescent | 71 | 2024 | 89169 | 0.580 |
Why?
|
| Intelligence | 4 | 2020 | 926 | 0.580 |
Why?
|
| Mental Health | 9 | 2022 | 3275 | 0.580 |
Why?
|
| Emotional Intelligence | 2 | 2016 | 135 | 0.570 |
Why?
|
| Case-Control Studies | 47 | 2024 | 22291 | 0.570 |
Why?
|
| Genetics | 1 | 2017 | 114 | 0.550 |
Why?
|
| Anger | 6 | 2019 | 405 | 0.540 |
Why?
|
| Genetic Pleiotropy | 5 | 2022 | 181 | 0.540 |
Why?
|
| Social Environment | 5 | 2014 | 1012 | 0.530 |
Why?
|
| Models, Genetic | 10 | 2019 | 3447 | 0.530 |
Why?
|
| Amygdala | 5 | 2021 | 1380 | 0.530 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 2008 | 500 | 0.530 |
Why?
|
| Folic Acid | 5 | 2017 | 1337 | 0.520 |
Why?
|
| Aftercare | 2 | 2023 | 916 | 0.520 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 2005 | 361 | 0.510 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 9 | 2013 | 326 | 0.500 |
Why?
|
| Gene Frequency | 18 | 2021 | 3623 | 0.480 |
Why?
|
| Mood Disorders | 4 | 2022 | 1129 | 0.480 |
Why?
|
| Child | 65 | 2024 | 80917 | 0.470 |
Why?
|
| Sertraline | 3 | 2013 | 209 | 0.460 |
Why?
|
| Affect | 3 | 2022 | 1495 | 0.460 |
Why?
|
| Vitamin B 12 | 2 | 2014 | 529 | 0.460 |
Why?
|
| Biological Specimen Banks | 7 | 2021 | 788 | 0.450 |
Why?
|
| Williams Syndrome | 1 | 2016 | 195 | 0.450 |
Why?
|
| Educational Status | 4 | 2022 | 2515 | 0.450 |
Why?
|
| Genetic Linkage | 12 | 2011 | 2342 | 0.440 |
Why?
|
| Longitudinal Studies | 25 | 2023 | 14783 | 0.430 |
Why?
|
| Theory of Mind | 1 | 2015 | 95 | 0.430 |
Why?
|
| Models, Statistical | 8 | 2024 | 5107 | 0.430 |
Why?
|
| Inheritance Patterns | 2 | 2015 | 344 | 0.430 |
Why?
|
| Genetic Testing | 8 | 2024 | 3591 | 0.430 |
Why?
|
| Mental Health Services | 2 | 2024 | 1732 | 0.430 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2024 | 3231 | 0.430 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 7 | 2014 | 417 | 0.430 |
Why?
|
| Vitamin B 6 | 1 | 2014 | 237 | 0.430 |
Why?
|
| Chromosomes, Human, Pair 6 | 4 | 2018 | 370 | 0.420 |
Why?
|
| Data Mining | 2 | 2018 | 563 | 0.420 |
Why?
|
| Temperament | 4 | 2009 | 301 | 0.410 |
Why?
|
| Emotions | 7 | 2022 | 2767 | 0.410 |
Why?
|
| Catechol O-Methyltransferase | 5 | 2016 | 251 | 0.400 |
Why?
|
| Cohort Studies | 34 | 2022 | 41754 | 0.390 |
Why?
|
| Glutamine | 2 | 2015 | 577 | 0.390 |
Why?
|
| Electrophysiology | 1 | 2015 | 1266 | 0.390 |
Why?
|
| Cyclonic Storms | 1 | 2013 | 121 | 0.390 |
Why?
|
| Genetic Markers | 15 | 2016 | 2603 | 0.380 |
Why?
|
| Exercise | 5 | 2024 | 5955 | 0.380 |
Why?
|
| Citalopram | 4 | 2014 | 401 | 0.380 |
Why?
|
| Chromosome Mapping | 14 | 2013 | 4620 | 0.370 |
Why?
|
| Glutaminase | 1 | 2011 | 31 | 0.370 |
Why?
|
| Alleles | 21 | 2022 | 6894 | 0.360 |
Why?
|
| DNA Copy Number Variations | 5 | 2018 | 2048 | 0.360 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 325 | 0.360 |
Why?
|
| Polymorphism, Genetic | 10 | 2015 | 4249 | 0.360 |
Why?
|
| Twin Studies as Topic | 5 | 2015 | 103 | 0.360 |
Why?
|
| Postmenopause | 5 | 2013 | 2518 | 0.360 |
Why?
|
| Aged | 57 | 2025 | 171504 | 0.350 |
Why?
|
| Bayes Theorem | 8 | 2024 | 2359 | 0.350 |
Why?
|
| Genetic Association Studies | 9 | 2025 | 2744 | 0.350 |
Why?
|
| Receptor, Serotonin, 5-HT1B | 3 | 2007 | 36 | 0.350 |
Why?
|
| Psychotropic Drugs | 4 | 2017 | 881 | 0.340 |
Why?
|
| Organ Size | 9 | 2024 | 2267 | 0.340 |
Why?
|
| Stress, Psychological | 5 | 2020 | 4530 | 0.340 |
Why?
|
| Vitamin D Deficiency | 1 | 2020 | 1388 | 0.340 |
Why?
|
| Magnetic Resonance Imaging | 32 | 2024 | 36743 | 0.340 |
Why?
|
| Child Development | 4 | 2015 | 2330 | 0.340 |
Why?
|
| Child Development Disorders, Pervasive | 3 | 2014 | 598 | 0.340 |
Why?
|
| Cost-Benefit Analysis | 3 | 2021 | 5536 | 0.340 |
Why?
|
| Minors | 1 | 2010 | 59 | 0.340 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2010 | 411 | 0.320 |
Why?
|
| Tourette Syndrome | 4 | 2021 | 400 | 0.320 |
Why?
|
| Tobacco Use Disorder | 4 | 2024 | 708 | 0.320 |
Why?
|
| Lithium Compounds | 4 | 2016 | 226 | 0.310 |
Why?
|
| Drug Repositioning | 2 | 2023 | 246 | 0.310 |
Why?
|
| Veterans | 4 | 2023 | 2669 | 0.310 |
Why?
|
| Genetics, Medical | 2 | 2015 | 334 | 0.300 |
Why?
|
| Prospective Studies | 23 | 2023 | 54926 | 0.300 |
Why?
|
| 1-Naphthylamine | 2 | 1998 | 48 | 0.300 |
Why?
|
| Primary Health Care | 2 | 2022 | 4746 | 0.300 |
Why?
|
| Sex Characteristics | 6 | 2021 | 2650 | 0.290 |
Why?
|
| Comorbidity | 18 | 2023 | 10590 | 0.290 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2008 | 57 | 0.290 |
Why?
|
| United States | 32 | 2024 | 73039 | 0.290 |
Why?
|
| Glycosylation | 5 | 2022 | 1100 | 0.290 |
Why?
|
| Natural Language Processing | 5 | 2018 | 1203 | 0.290 |
Why?
|
| Harm Reduction | 1 | 2009 | 143 | 0.290 |
Why?
|
| Cardiovascular Diseases | 9 | 2024 | 15662 | 0.290 |
Why?
|
| Risk | 9 | 2023 | 9613 | 0.290 |
Why?
|
| Disasters | 1 | 2013 | 521 | 0.280 |
Why?
|
| Life Change Events | 5 | 2022 | 960 | 0.280 |
Why?
|
| Self Report | 7 | 2022 | 3773 | 0.280 |
Why?
|
| Psychiatric Status Rating Scales | 16 | 2017 | 6029 | 0.270 |
Why?
|
| Synaptic Transmission | 1 | 2012 | 1177 | 0.260 |
Why?
|
| Polysaccharides | 3 | 2023 | 1024 | 0.260 |
Why?
|
| Algorithms | 12 | 2024 | 14164 | 0.260 |
Why?
|
| Obstetric Labor Complications | 2 | 2019 | 244 | 0.260 |
Why?
|
| Disease | 2 | 2021 | 675 | 0.250 |
Why?
|
| Delivery of Health Care | 3 | 2020 | 5367 | 0.250 |
Why?
|
| Somatoform Disorders | 1 | 2009 | 425 | 0.250 |
Why?
|
| Emergency Service, Hospital | 4 | 2024 | 7951 | 0.250 |
Why?
|
| Brain-Derived Neurotrophic Factor | 4 | 2013 | 605 | 0.250 |
Why?
|
| Genetic Research | 3 | 2021 | 173 | 0.250 |
Why?
|
| Self-Injurious Behavior | 2 | 2024 | 568 | 0.250 |
Why?
|
| Hippocampus | 7 | 2021 | 3785 | 0.250 |
Why?
|
| Genetic Heterogeneity | 4 | 2024 | 736 | 0.240 |
Why?
|
| Biomedical Research | 3 | 2021 | 3463 | 0.240 |
Why?
|
| Brain Chemistry | 2 | 2008 | 958 | 0.240 |
Why?
|
| Reproducibility of Results | 12 | 2024 | 20227 | 0.240 |
Why?
|
| Environment | 3 | 2020 | 1121 | 0.240 |
Why?
|
| Meta-Analysis as Topic | 7 | 2020 | 1363 | 0.240 |
Why?
|
| Affective Disorders, Psychotic | 2 | 2017 | 187 | 0.240 |
Why?
|
| Dementia | 3 | 2014 | 2740 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 12 | 4 | 2012 | 432 | 0.240 |
Why?
|
| Obsessive-Compulsive Disorder | 7 | 2021 | 1508 | 0.240 |
Why?
|
| Age of Onset | 8 | 2021 | 3347 | 0.240 |
Why?
|
| Haplotypes | 8 | 2019 | 2722 | 0.230 |
Why?
|
| Nervous System Diseases | 3 | 2022 | 1662 | 0.230 |
Why?
|
| Databases, Genetic | 4 | 2019 | 1758 | 0.230 |
Why?
|
| Antidepressive Agents, Second-Generation | 4 | 2014 | 491 | 0.230 |
Why?
|
| Dissociative Disorders | 2 | 2022 | 235 | 0.230 |
Why?
|
| Dyspnea | 4 | 2006 | 1352 | 0.230 |
Why?
|
| Nerve Net | 5 | 2016 | 2352 | 0.230 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 1083 | 0.220 |
Why?
|
| Personality Inventory | 5 | 2011 | 1018 | 0.220 |
Why?
|
| Cross-Sectional Studies | 16 | 2022 | 26379 | 0.220 |
Why?
|
| ROC Curve | 4 | 2023 | 3628 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 9 | 2017 | 4413 | 0.220 |
Why?
|
| Rats, Zucker | 3 | 1995 | 131 | 0.220 |
Why?
|
| National Institute of Mental Health (U.S.) | 2 | 2016 | 108 | 0.210 |
Why?
|
| Parents | 6 | 2024 | 3595 | 0.210 |
Why?
|
| Logistic Models | 12 | 2021 | 13290 | 0.210 |
Why?
|
| Mendelian Randomization Analysis | 4 | 2023 | 1040 | 0.210 |
Why?
|
| Brain Diseases | 3 | 2018 | 1554 | 0.210 |
Why?
|
| Penetrance | 3 | 2019 | 385 | 0.210 |
Why?
|
| Multicenter Studies as Topic | 2 | 2020 | 1737 | 0.210 |
Why?
|
| Marital Status | 2 | 2022 | 426 | 0.210 |
Why?
|
| Selection Bias | 2 | 2023 | 360 | 0.210 |
Why?
|
| Molecular Biology | 5 | 2023 | 573 | 0.210 |
Why?
|
| Sex Factors | 10 | 2020 | 10632 | 0.210 |
Why?
|
| Heredity | 1 | 2023 | 149 | 0.210 |
Why?
|
| Bupropion | 2 | 2022 | 303 | 0.200 |
Why?
|
| Stroke | 2 | 2018 | 9755 | 0.200 |
Why?
|
| Divorce | 1 | 2022 | 78 | 0.200 |
Why?
|
| Nepal | 1 | 2023 | 301 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2024 | 12252 | 0.200 |
Why?
|
| Health Surveys | 7 | 2020 | 4057 | 0.200 |
Why?
|
| Alzheimer Disease | 9 | 2018 | 8759 | 0.200 |
Why?
|
| Multivariate Analysis | 8 | 2019 | 12077 | 0.200 |
Why?
|
| Genome | 4 | 2023 | 1754 | 0.200 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 2 | 2013 | 88 | 0.190 |
Why?
|
| Genetic Counseling | 1 | 2006 | 635 | 0.190 |
Why?
|
| Drug Resistance | 1 | 2008 | 1599 | 0.190 |
Why?
|
| Receptors, Dopamine D4 | 4 | 2014 | 168 | 0.190 |
Why?
|
| Mutation, Missense | 5 | 2020 | 2592 | 0.190 |
Why?
|
| Socioeconomic Factors | 7 | 2020 | 7852 | 0.190 |
Why?
|
| Fear | 2 | 2019 | 1495 | 0.190 |
Why?
|
| Carrier Proteins | 5 | 2020 | 4937 | 0.190 |
Why?
|
| History, 21st Century | 2 | 2018 | 1573 | 0.190 |
Why?
|
| Brain Mapping | 8 | 2020 | 6685 | 0.190 |
Why?
|
| Pregnancy Complications | 4 | 2019 | 2973 | 0.190 |
Why?
|
| Reward | 3 | 2016 | 981 | 0.190 |
Why?
|
| Family Health | 5 | 2009 | 1255 | 0.180 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 2 | 2013 | 66 | 0.180 |
Why?
|
| History, 20th Century | 3 | 2018 | 2766 | 0.180 |
Why?
|
| Alcohol Drinking | 2 | 2024 | 4045 | 0.180 |
Why?
|
| Pandemics | 5 | 2024 | 8748 | 0.180 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2020 | 50 | 0.180 |
Why?
|
| Evoked Potentials, Auditory | 2 | 2015 | 533 | 0.170 |
Why?
|
| DNA | 5 | 2021 | 7214 | 0.170 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2020 | 71 | 0.170 |
Why?
|
| Genetic Techniques | 2 | 2017 | 428 | 0.170 |
Why?
|
| Glutamate Decarboxylase | 1 | 2001 | 239 | 0.170 |
Why?
|
| Antimanic Agents | 3 | 2015 | 524 | 0.170 |
Why?
|
| Neuropsychological Tests | 8 | 2020 | 7140 | 0.170 |
Why?
|
| New England | 5 | 2017 | 1058 | 0.170 |
Why?
|
| Protoporphyria, Erythropoietic | 1 | 2020 | 54 | 0.170 |
Why?
|
| Data Interpretation, Statistical | 5 | 2020 | 2709 | 0.170 |
Why?
|
| Lung Diseases, Obstructive | 2 | 1998 | 311 | 0.170 |
Why?
|
| Prefrontal Cortex | 3 | 2020 | 2238 | 0.170 |
Why?
|
| Child, Preschool | 18 | 2024 | 42669 | 0.170 |
Why?
|
| Fluoxetine | 2 | 2003 | 733 | 0.170 |
Why?
|
| Placebo Effect | 2 | 2014 | 517 | 0.170 |
Why?
|
| Chest Pain | 1 | 2006 | 1101 | 0.170 |
Why?
|
| Multiple Trauma | 1 | 2022 | 369 | 0.170 |
Why?
|
| Marijuana Abuse | 1 | 2023 | 409 | 0.160 |
Why?
|
| Avoidance Learning | 3 | 2010 | 248 | 0.160 |
Why?
|
| Endophenotypes | 3 | 2017 | 259 | 0.160 |
Why?
|
| Stress Disorders, Traumatic | 1 | 2019 | 50 | 0.160 |
Why?
|
| Women's Health | 4 | 2017 | 2082 | 0.160 |
Why?
|
| Receptors, Dopamine D5 | 3 | 2007 | 32 | 0.160 |
Why?
|
| Synaptosomal-Associated Protein 25 | 3 | 2007 | 50 | 0.160 |
Why?
|
| Adaptation, Psychological | 3 | 2019 | 2663 | 0.160 |
Why?
|
| Glycomics | 1 | 2020 | 118 | 0.160 |
Why?
|
| Tacrolimus Binding Proteins | 2 | 2013 | 199 | 0.160 |
Why?
|
| Sensitivity and Specificity | 6 | 2021 | 14729 | 0.160 |
Why?
|
| Databases, Factual | 7 | 2024 | 8080 | 0.160 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 355 | 0.160 |
Why?
|
| Schizophrenic Psychology | 3 | 2016 | 1649 | 0.160 |
Why?
|
| Substance-Related Disorders | 6 | 2024 | 4423 | 0.160 |
Why?
|
| Happiness | 2 | 2019 | 170 | 0.160 |
Why?
|
| Frontal Lobe | 3 | 2015 | 1426 | 0.150 |
Why?
|
| Databases as Topic | 1 | 2020 | 472 | 0.150 |
Why?
|
| Wills | 1 | 2017 | 13 | 0.150 |
Why?
|
| Twins | 2 | 2016 | 341 | 0.150 |
Why?
|
| Chromosome Aberrations | 3 | 2021 | 1778 | 0.150 |
Why?
|
| Menstrual Cycle | 2 | 2018 | 546 | 0.150 |
Why?
|
| Event-Related Potentials, P300 | 2 | 2015 | 149 | 0.150 |
Why?
|
| Gyrus Cinguli | 5 | 2016 | 1135 | 0.150 |
Why?
|
| Beauty | 2 | 2015 | 41 | 0.150 |
Why?
|
| Follow-Up Studies | 12 | 2017 | 39348 | 0.150 |
Why?
|
| Tic Disorders | 1 | 2019 | 140 | 0.150 |
Why?
|
| Aging | 6 | 2024 | 8744 | 0.150 |
Why?
|
| Impulsive Behavior | 2 | 2021 | 345 | 0.140 |
Why?
|
| Pain | 3 | 2022 | 5100 | 0.140 |
Why?
|
| Quantitative Trait Loci | 5 | 2021 | 2131 | 0.140 |
Why?
|
| Afghan Campaign 2001- | 1 | 2019 | 298 | 0.140 |
Why?
|
| Massachusetts | 4 | 2024 | 8890 | 0.140 |
Why?
|
| Basal Ganglia | 1 | 2020 | 553 | 0.140 |
Why?
|
| Minority Groups | 2 | 2023 | 1216 | 0.140 |
Why?
|
| History, 19th Century | 2 | 2018 | 714 | 0.140 |
Why?
|
| Social Class | 2 | 2017 | 2008 | 0.140 |
Why?
|
| Chromosomes, Human | 2 | 2021 | 438 | 0.140 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2018 | 271 | 0.140 |
Why?
|
| Pregnancy | 9 | 2023 | 30256 | 0.140 |
Why?
|
| Tetrahydrofolates | 1 | 2017 | 58 | 0.140 |
Why?
|
| Premenstrual Syndrome | 1 | 1997 | 111 | 0.140 |
Why?
|
| Odds Ratio | 5 | 2021 | 9669 | 0.140 |
Why?
|
| Corpus Striatum | 2 | 2021 | 1224 | 0.140 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2014 | 276 | 0.130 |
Why?
|
| Transcription Factors | 2 | 2013 | 12168 | 0.130 |
Why?
|
| Glycoproteins | 2 | 2022 | 2202 | 0.130 |
Why?
|
| Biomarkers, Pharmacological | 2 | 2015 | 162 | 0.130 |
Why?
|
| Pedigree | 5 | 2019 | 4539 | 0.130 |
Why?
|
| Neuroanatomy | 1 | 2016 | 73 | 0.130 |
Why?
|
| Kynurenic Acid | 1 | 2015 | 44 | 0.130 |
Why?
|
| Incidence | 6 | 2017 | 21538 | 0.130 |
Why?
|
| Myocardial Ischemia | 1 | 2006 | 2138 | 0.130 |
Why?
|
| Family | 8 | 2014 | 3209 | 0.130 |
Why?
|
| Obesity | 8 | 2021 | 13090 | 0.130 |
Why?
|
| Interview, Psychological | 1 | 2019 | 810 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2018 | 1143 | 0.130 |
Why?
|
| Huntington Disease | 2 | 2015 | 1147 | 0.130 |
Why?
|
| Remission Induction | 3 | 2024 | 2410 | 0.130 |
Why?
|
| Lithium | 2 | 2015 | 600 | 0.130 |
Why?
|
| Prevalence | 11 | 2021 | 15869 | 0.120 |
Why?
|
| Schools | 2 | 2022 | 1498 | 0.120 |
Why?
|
| Autistic Disorder | 2 | 2023 | 1240 | 0.120 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2021 | 747 | 0.120 |
Why?
|
| Adolescent Behavior | 1 | 2024 | 1186 | 0.120 |
Why?
|
| Erectile Dysfunction | 1 | 2018 | 437 | 0.120 |
Why?
|
| Psychology | 1 | 2017 | 353 | 0.120 |
Why?
|
| Linear Models | 8 | 2019 | 5884 | 0.120 |
Why?
|
| Individuality | 2 | 2016 | 307 | 0.120 |
Why?
|
| Exploratory Behavior | 1 | 2016 | 272 | 0.120 |
Why?
|
| Computer Simulation | 6 | 2019 | 6283 | 0.120 |
Why?
|
| Aged, 80 and over | 13 | 2024 | 59629 | 0.120 |
Why?
|
| Models, Animal | 1 | 2001 | 2120 | 0.120 |
Why?
|
| Thalamus | 1 | 2021 | 1047 | 0.120 |
Why?
|
| Physician-Patient Relations | 2 | 2022 | 3269 | 0.120 |
Why?
|
| Cognition Disorders | 4 | 2017 | 3980 | 0.120 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2014 | 50 | 0.110 |
Why?
|
| Appointments and Schedules | 1 | 1998 | 443 | 0.110 |
Why?
|
| Reproduction | 1 | 2018 | 646 | 0.110 |
Why?
|
| Microvessels | 1 | 2018 | 585 | 0.110 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2014 | 33 | 0.110 |
Why?
|
| New Orleans | 1 | 2013 | 27 | 0.110 |
Why?
|
| Trinucleotide Repeats | 1 | 2015 | 257 | 0.110 |
Why?
|
| Child Behavior Disorders | 2 | 2017 | 812 | 0.110 |
Why?
|
| Intelligence Tests | 1 | 2015 | 504 | 0.110 |
Why?
|
| Functional Laterality | 1 | 2020 | 2264 | 0.110 |
Why?
|
| Ankyrins | 2 | 2017 | 123 | 0.110 |
Why?
|
| Esthetics | 1 | 2015 | 328 | 0.110 |
Why?
|
| Motor Activity | 3 | 2015 | 2711 | 0.110 |
Why?
|
| Apolipoprotein E4 | 1 | 2018 | 712 | 0.110 |
Why?
|
| Hypothalamus | 1 | 2018 | 1004 | 0.110 |
Why?
|
| Achievement | 1 | 2015 | 288 | 0.110 |
Why?
|
| Likelihood Functions | 3 | 2011 | 994 | 0.110 |
Why?
|
| Residence Characteristics | 1 | 2023 | 2118 | 0.110 |
Why?
|
| Publication Bias | 1 | 2014 | 158 | 0.110 |
Why?
|
| Post-Concussion Syndrome | 1 | 2016 | 257 | 0.110 |
Why?
|
| Pattern Recognition, Visual | 2 | 2010 | 826 | 0.110 |
Why?
|
| Receptors, Dopamine | 1 | 2014 | 293 | 0.110 |
Why?
|
| Attitude of Health Personnel | 2 | 2005 | 3929 | 0.110 |
Why?
|
| Diet, Reducing | 2 | 1987 | 487 | 0.110 |
Why?
|
| Receptors, Oxytocin | 1 | 2013 | 71 | 0.110 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2015 | 270 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2015 | 3780 | 0.100 |
Why?
|
| Amyloid | 1 | 2018 | 854 | 0.100 |
Why?
|
| Communicable Diseases | 1 | 2021 | 874 | 0.100 |
Why?
|
| Mental Recall | 1 | 2019 | 1226 | 0.100 |
Why?
|
| Neurologic Examination | 1 | 2015 | 914 | 0.100 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2014 | 430 | 0.100 |
Why?
|
| Pain Perception | 1 | 2014 | 198 | 0.100 |
Why?
|
| Parkinson Disease | 4 | 2024 | 2893 | 0.100 |
Why?
|
| Chronic Disease | 3 | 2024 | 9384 | 0.100 |
Why?
|
| Evoked Potentials | 2 | 2018 | 1058 | 0.100 |
Why?
|
| Research Design | 5 | 2019 | 6211 | 0.100 |
Why?
|
| Climacteric | 1 | 2012 | 57 | 0.100 |
Why?
|
| Diseases in Twins | 2 | 2008 | 447 | 0.100 |
Why?
|
| Registries | 4 | 2018 | 8375 | 0.100 |
Why?
|
| Animals | 18 | 2023 | 169246 | 0.100 |
Why?
|
| Metabolomics | 1 | 2021 | 1674 | 0.100 |
Why?
|
| Research | 2 | 2014 | 1979 | 0.100 |
Why?
|
| Mutation | 4 | 2022 | 30238 | 0.100 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2018 | 1196 | 0.100 |
Why?
|
| ADAM Proteins | 1 | 2013 | 242 | 0.100 |
Why?
|
| Social Support | 1 | 2022 | 2193 | 0.100 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2015 | 301 | 0.100 |
Why?
|
| alpha Catenin | 1 | 2011 | 37 | 0.100 |
Why?
|
| Prognosis | 5 | 2024 | 30010 | 0.100 |
Why?
|
| Psychotherapy | 2 | 1998 | 1654 | 0.100 |
Why?
|
| Motor Cortex | 1 | 2019 | 1013 | 0.100 |
Why?
|
| Coronary Artery Disease | 3 | 2021 | 6568 | 0.100 |
Why?
|
| Research Support as Topic | 1 | 2016 | 696 | 0.090 |
Why?
|
| Antipsychotic Agents | 4 | 2017 | 3081 | 0.090 |
Why?
|
| Treatment Outcome | 12 | 2017 | 65371 | 0.090 |
Why?
|
| Temporal Lobe | 1 | 2019 | 1726 | 0.090 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2011 | 53 | 0.090 |
Why?
|
| Receptors, Nicotinic | 2 | 2012 | 494 | 0.090 |
Why?
|
| Executive Function | 2 | 2020 | 1401 | 0.090 |
Why?
|
| Infant, Newborn | 5 | 2023 | 26422 | 0.090 |
Why?
|
| Asthma | 2 | 2022 | 6291 | 0.090 |
Why?
|
| Infant | 8 | 2021 | 36535 | 0.090 |
Why?
|
| Psychomotor Agitation | 2 | 2011 | 307 | 0.090 |
Why?
|
| Diet | 2 | 2020 | 8089 | 0.090 |
Why?
|
| Migraine Disorders | 1 | 2003 | 1713 | 0.090 |
Why?
|
| Philosophy, Medical | 1 | 1991 | 78 | 0.090 |
Why?
|
| Obesity, Morbid | 1 | 2021 | 1298 | 0.090 |
Why?
|
| Receptors, AMPA | 2 | 2009 | 334 | 0.090 |
Why?
|
| Respiratory Tract Diseases | 1 | 1996 | 744 | 0.090 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2010 | 64 | 0.090 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2010 | 58 | 0.090 |
Why?
|
| Adrenomedullin | 1 | 2010 | 85 | 0.090 |
Why?
|
| Students | 2 | 2024 | 1744 | 0.090 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 1726 | 0.090 |
Why?
|
| Personality Assessment | 2 | 2010 | 646 | 0.090 |
Why?
|
| Body Mass Index | 4 | 2021 | 13053 | 0.090 |
Why?
|
| Child Behavior | 2 | 2010 | 864 | 0.090 |
Why?
|
| Smoking | 3 | 2012 | 9092 | 0.090 |
Why?
|
| Pregnancy Outcome | 2 | 2019 | 2972 | 0.090 |
Why?
|
| Wit and Humor as Topic | 1 | 2010 | 31 | 0.090 |
Why?
|
| Professional Practice | 2 | 2005 | 314 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2011 | 313 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1901 | 0.080 |
Why?
|
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2009 | 31 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2015 | 640 | 0.080 |
Why?
|
| Motor Vehicles | 2 | 2022 | 280 | 0.080 |
Why?
|
| Limbic System | 1 | 2012 | 424 | 0.080 |
Why?
|
| Breast Neoplasms | 3 | 2023 | 21206 | 0.080 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2018 | 1107 | 0.080 |
Why?
|
| Proportional Hazards Models | 3 | 2014 | 12543 | 0.080 |
Why?
|
| Renal Insufficiency | 1 | 2015 | 812 | 0.080 |
Why?
|
| Ventral Tegmental Area | 1 | 2010 | 135 | 0.080 |
Why?
|
| Pneumonia | 1 | 2021 | 2163 | 0.080 |
Why?
|
| Disease Management | 1 | 2020 | 2536 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2005 | 4858 | 0.080 |
Why?
|
| Face | 1 | 2015 | 1029 | 0.080 |
Why?
|
| Brain Waves | 1 | 2013 | 417 | 0.080 |
Why?
|
| Adolescent Development | 1 | 2012 | 276 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2011 | 458 | 0.080 |
Why?
|
| Substantia Nigra | 1 | 2010 | 346 | 0.080 |
Why?
|
| Genes | 1 | 1993 | 1824 | 0.080 |
Why?
|
| Neutrophils | 1 | 2021 | 3786 | 0.080 |
Why?
|
| Acupuncture Therapy | 1 | 2013 | 486 | 0.080 |
Why?
|
| Lung Diseases | 1 | 1999 | 1944 | 0.080 |
Why?
|
| Propaganda | 1 | 2008 | 7 | 0.080 |
Why?
|
| Lithium Carbonate | 1 | 2009 | 179 | 0.080 |
Why?
|
| Cause of Death | 2 | 2010 | 3721 | 0.080 |
Why?
|
| Monoamine Oxidase | 1 | 2008 | 180 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 2 | 2017 | 1327 | 0.080 |
Why?
|
| Accidents, Traffic | 3 | 2022 | 818 | 0.080 |
Why?
|
| Myosin Type V | 1 | 2008 | 33 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 10 | 3 | 2017 | 275 | 0.070 |
Why?
|
| Excitatory Amino Acid Transporter 3 | 1 | 2007 | 32 | 0.070 |
Why?
|
| Arousal | 2 | 2008 | 1180 | 0.070 |
Why?
|
| Retrospective Studies | 10 | 2024 | 81762 | 0.070 |
Why?
|
| Neurodegenerative Diseases | 2 | 2014 | 1095 | 0.070 |
Why?
|
| Neuroglia | 1 | 2014 | 960 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 2298 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2010 | 452 | 0.070 |
Why?
|
| Severity of Illness Index | 9 | 2019 | 15948 | 0.070 |
Why?
|
| Patient Compliance | 1 | 1998 | 2697 | 0.070 |
Why?
|
| Multiple Sclerosis | 1 | 2023 | 3250 | 0.070 |
Why?
|
| Europe | 3 | 2020 | 3436 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2008 | 323 | 0.070 |
Why?
|
| Parietal Lobe | 1 | 2012 | 866 | 0.070 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 2188 | 0.070 |
Why?
|
| Major Histocompatibility Complex | 2 | 2021 | 877 | 0.070 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2009 | 193 | 0.070 |
Why?
|
| Genes, Immediate-Early | 1 | 2007 | 102 | 0.070 |
Why?
|
| Mass Screening | 2 | 2022 | 5458 | 0.070 |
Why?
|
| Software | 3 | 2024 | 4478 | 0.070 |
Why?
|
| Siblings | 3 | 2008 | 828 | 0.070 |
Why?
|
| Sepsis | 1 | 2021 | 2608 | 0.070 |
Why?
|
| Cardiology | 1 | 2018 | 1702 | 0.070 |
Why?
|
| Genetics, Population | 2 | 2019 | 944 | 0.070 |
Why?
|
| Adoption | 2 | 2005 | 97 | 0.070 |
Why?
|
| Computational Biology | 2 | 2019 | 3568 | 0.070 |
Why?
|
| Neural Pathways | 4 | 2024 | 3117 | 0.070 |
Why?
|
| Brazil | 2 | 2021 | 1250 | 0.070 |
Why?
|
| Electrocardiography | 2 | 2013 | 6412 | 0.070 |
Why?
|
| Membrane Glycoproteins | 3 | 2008 | 3711 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2014 | 10399 | 0.070 |
Why?
|
| Mental Processes | 1 | 2008 | 246 | 0.070 |
Why?
|
| Frail Elderly | 1 | 2012 | 781 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3252 | 0.070 |
Why?
|
| Benzodiazepines | 2 | 2010 | 1138 | 0.070 |
Why?
|
| Models, Psychological | 2 | 2024 | 825 | 0.070 |
Why?
|
| Jejunoileal Bypass | 1 | 1986 | 13 | 0.070 |
Why?
|
| Membrane Proteins | 3 | 2020 | 7876 | 0.070 |
Why?
|
| Electroencephalography | 4 | 2017 | 6314 | 0.070 |
Why?
|
| Rodentia | 1 | 2008 | 262 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2017 | 2596 | 0.070 |
Why?
|
| Myosin Heavy Chains | 1 | 2008 | 404 | 0.070 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 11928 | 0.070 |
Why?
|
| Social Behavior | 1 | 2012 | 1147 | 0.060 |
Why?
|
| Vitamin D | 1 | 2020 | 3311 | 0.060 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2005 | 29 | 0.060 |
Why?
|
| Sample Size | 2 | 2024 | 846 | 0.060 |
Why?
|
| Memory | 1 | 2015 | 2208 | 0.060 |
Why?
|
| Regression Analysis | 4 | 2014 | 6340 | 0.060 |
Why?
|
| Chromosome Breakage | 1 | 2006 | 159 | 0.060 |
Why?
|
| Protein Precursors | 2 | 2018 | 1134 | 0.060 |
Why?
|
| RNA | 2 | 2013 | 2720 | 0.060 |
Why?
|
| Statistics, Nonparametric | 5 | 2017 | 2862 | 0.060 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2006 | 108 | 0.060 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 5889 | 0.060 |
Why?
|
| Protons | 1 | 2011 | 1113 | 0.060 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2009 | 364 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2015 | 2538 | 0.060 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2012 | 1209 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2008 | 458 | 0.060 |
Why?
|
| Canada | 1 | 2010 | 2130 | 0.060 |
Why?
|
| Amyloid beta-Peptides | 2 | 2016 | 3914 | 0.060 |
Why?
|
| Ambulatory Care | 2 | 2011 | 2783 | 0.060 |
Why?
|
| Low Back Pain | 1 | 2013 | 990 | 0.060 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2006 | 246 | 0.060 |
Why?
|
| Mixed Function Oxygenases | 1 | 2006 | 265 | 0.060 |
Why?
|
| Inflammation | 2 | 2023 | 10873 | 0.060 |
Why?
|
| Proteoglycans | 2 | 2022 | 809 | 0.060 |
Why?
|
| Social Isolation | 1 | 2007 | 366 | 0.060 |
Why?
|
| Repressor Proteins | 3 | 2020 | 2982 | 0.060 |
Why?
|
| Psychological Tests | 1 | 1987 | 643 | 0.060 |
Why?
|
| Age Factors | 4 | 2019 | 18412 | 0.060 |
Why?
|
| Parenting | 1 | 2010 | 708 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2019 | 2442 | 0.060 |
Why?
|
| Knowledge Bases | 1 | 2024 | 97 | 0.060 |
Why?
|
| Anti-Anxiety Agents | 2 | 1998 | 405 | 0.060 |
Why?
|
| Statistics as Topic | 3 | 2016 | 2357 | 0.060 |
Why?
|
| Weight Gain | 1 | 2014 | 2359 | 0.060 |
Why?
|
| Mice | 7 | 2023 | 82029 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2017 | 3007 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2019 | 3781 | 0.050 |
Why?
|
| Hypertension | 2 | 2021 | 8616 | 0.050 |
Why?
|
| Lod Score | 2 | 2001 | 600 | 0.050 |
Why?
|
| Cues | 3 | 2013 | 878 | 0.050 |
Why?
|
| Activities of Daily Living | 2 | 2017 | 2430 | 0.050 |
Why?
|
| Psychological Theory | 1 | 2024 | 173 | 0.050 |
Why?
|
| Neurobiology | 1 | 2024 | 135 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2008 | 951 | 0.050 |
Why?
|
| Hybridization, Genetic | 2 | 1993 | 102 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 2258 | 0.050 |
Why?
|
| Models, Theoretical | 2 | 2013 | 3573 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7454 | 0.050 |
Why?
|
| Nuclear Family | 2 | 2001 | 311 | 0.050 |
Why?
|
| Fathers | 1 | 2005 | 377 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2271 | 0.050 |
Why?
|
| Attention | 3 | 2010 | 2424 | 0.050 |
Why?
|
| Duty to Recontact | 1 | 2021 | 19 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2003 | 615 | 0.050 |
Why?
|
| Time Factors | 4 | 2020 | 40218 | 0.050 |
Why?
|
| Atrophy | 2 | 2018 | 1646 | 0.050 |
Why?
|
| Glutamate Carboxypeptidase II | 2 | 2013 | 90 | 0.050 |
Why?
|
| Attitude to Health | 1 | 1991 | 2025 | 0.050 |
Why?
|
| Reference Values | 4 | 2011 | 4938 | 0.050 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2022 | 57 | 0.050 |
Why?
|
| Mannose | 1 | 2022 | 122 | 0.050 |
Why?
|
| Acute-Phase Proteins | 1 | 2023 | 252 | 0.050 |
Why?
|
| Stomach | 1 | 1986 | 701 | 0.050 |
Why?
|
| Poverty | 1 | 2013 | 2720 | 0.050 |
Why?
|
| Drug Industry | 1 | 2008 | 791 | 0.050 |
Why?
|
| Sulfurtransferases | 1 | 2021 | 17 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2012 | 2420 | 0.050 |
Why?
|
| Acetylglucosamine | 1 | 2023 | 189 | 0.050 |
Why?
|
| Membrane Transport Proteins | 2 | 2005 | 1037 | 0.050 |
Why?
|
| Sleep | 1 | 2017 | 4819 | 0.050 |
Why?
|
| Trace Elements | 1 | 2023 | 193 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2017 | 8543 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 762 | 0.050 |
Why?
|
| Enkephalins | 1 | 2001 | 139 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2022 | 2732 | 0.050 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2001 | 108 | 0.050 |
Why?
|
| Leukopoiesis | 1 | 2020 | 54 | 0.040 |
Why?
|
| Ferrochelatase | 1 | 2020 | 47 | 0.040 |
Why?
|
| Decision Support Techniques | 2 | 2008 | 2008 | 0.040 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2001 | 129 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4580 | 0.040 |
Why?
|
| Sex Offenses | 1 | 2025 | 357 | 0.040 |
Why?
|
| Personality Development | 1 | 2001 | 241 | 0.040 |
Why?
|
| Receptors, Kainic Acid | 1 | 2020 | 91 | 0.040 |
Why?
|
| Infant Behavior | 1 | 2001 | 157 | 0.040 |
Why?
|
| Serotonin | 1 | 2005 | 1043 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2017 | 9015 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2008 | 1997 | 0.040 |
Why?
|
| Education, Medical, Continuing | 1 | 2005 | 829 | 0.040 |
Why?
|
| Proteins | 1 | 2014 | 6009 | 0.040 |
Why?
|
| Telomere | 1 | 2006 | 944 | 0.040 |
Why?
|
| Digestive System Diseases | 1 | 2021 | 152 | 0.040 |
Why?
|
| Apolipoproteins E | 2 | 2018 | 1461 | 0.040 |
Why?
|
| Tics | 1 | 2000 | 76 | 0.040 |
Why?
|
| Transferrin | 1 | 2020 | 283 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 4120 | 0.040 |
Why?
|
| Mortality | 1 | 2010 | 2911 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2013 | 2107 | 0.040 |
Why?
|
| Jurisprudence | 1 | 1999 | 109 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2012 | 361 | 0.040 |
Why?
|
| Crime | 1 | 2020 | 206 | 0.040 |
Why?
|
| Germany | 2 | 2011 | 883 | 0.040 |
Why?
|
| Education, Medical | 1 | 1991 | 1742 | 0.040 |
Why?
|
| Pain Measurement | 3 | 2014 | 3583 | 0.040 |
Why?
|
| Double-Blind Method | 4 | 2017 | 12465 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2021 | 996 | 0.040 |
Why?
|
| Privacy | 1 | 2021 | 233 | 0.040 |
Why?
|
| Recurrence | 2 | 2014 | 8509 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 4528 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2009 | 10101 | 0.040 |
Why?
|
| Physician's Role | 1 | 2005 | 925 | 0.040 |
Why?
|
| Demography | 2 | 2015 | 1641 | 0.040 |
Why?
|
| Agoraphobia | 1 | 1998 | 177 | 0.040 |
Why?
|
| Urogenital Abnormalities | 1 | 2021 | 255 | 0.040 |
Why?
|
| Internet | 2 | 2024 | 3110 | 0.040 |
Why?
|
| Whole Body Imaging | 1 | 2020 | 284 | 0.040 |
Why?
|
| Psychology, Clinical | 1 | 1998 | 43 | 0.040 |
Why?
|
| Communication | 2 | 2024 | 3905 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2024 | 1407 | 0.040 |
Why?
|
| Noise | 1 | 2020 | 295 | 0.040 |
Why?
|
| Hospitalization | 1 | 2018 | 10840 | 0.040 |
Why?
|
| Anisotropy | 2 | 2012 | 1292 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 1 | 2003 | 757 | 0.040 |
Why?
|
| Marriage | 2 | 1992 | 351 | 0.040 |
Why?
|
| Mosaicism | 1 | 2021 | 480 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2021 | 1609 | 0.040 |
Why?
|
| Gene Duplication | 1 | 2018 | 315 | 0.040 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 662 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2001 | 677 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 832 | 0.040 |
Why?
|
| Health Status | 2 | 2007 | 4091 | 0.040 |
Why?
|
| Cooperative Behavior | 2 | 2015 | 1514 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2011 | 4428 | 0.030 |
Why?
|
| Luteal Phase | 1 | 1997 | 138 | 0.030 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2016 | 67 | 0.030 |
Why?
|
| Ethanol | 1 | 2023 | 1331 | 0.030 |
Why?
|
| Disease Progression | 2 | 2011 | 13671 | 0.030 |
Why?
|
| Social Work | 1 | 1998 | 158 | 0.030 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2017 | 93 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2020 | 1534 | 0.030 |
Why?
|
| Folic Acid Deficiency | 1 | 2017 | 117 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 903 | 0.030 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2017 | 77 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 130 | 0.030 |
Why?
|
| Hot Temperature | 2 | 2013 | 1441 | 0.030 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2016 | 13 | 0.030 |
Why?
|
| Wound Healing | 1 | 2007 | 2809 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 1831 | 0.030 |
Why?
|
| Lipids | 2 | 2021 | 3343 | 0.030 |
Why?
|
| Aminopeptidases | 1 | 2017 | 114 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1135 | 0.030 |
Why?
|
| Food, Fortified | 1 | 2017 | 189 | 0.030 |
Why?
|
| Sorting Nexins | 1 | 2015 | 25 | 0.030 |
Why?
|
| Vasculitis | 1 | 2020 | 525 | 0.030 |
Why?
|
| Data Collection | 1 | 2005 | 3327 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2009 | 3239 | 0.030 |
Why?
|
| Nutritional Requirements | 1 | 2017 | 279 | 0.030 |
Why?
|
| Rats | 4 | 2007 | 23760 | 0.030 |
Why?
|
| Patient Dropouts | 1 | 1998 | 411 | 0.030 |
Why?
|
| Homozygote | 2 | 2016 | 1779 | 0.030 |
Why?
|
| Muscle Tonus | 1 | 2015 | 82 | 0.030 |
Why?
|
| Pulmonary Ventilation | 1 | 1998 | 375 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2021 | 830 | 0.030 |
Why?
|
| Disclosure | 1 | 2021 | 755 | 0.030 |
Why?
|
| Cerebellum | 1 | 2023 | 1522 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2016 | 2885 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2017 | 238 | 0.030 |
Why?
|
| Outpatients | 2 | 2019 | 1600 | 0.030 |
Why?
|
| Decision Making | 1 | 2009 | 3953 | 0.030 |
Why?
|
| Cyclohexanols | 1 | 1996 | 126 | 0.030 |
Why?
|
| Systems Biology | 1 | 2019 | 482 | 0.030 |
Why?
|
| Cytokines | 1 | 2010 | 7453 | 0.030 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2019 | 494 | 0.030 |
Why?
|
| International Cooperation | 2 | 2013 | 1436 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2016 | 350 | 0.030 |
Why?
|
| Vasomotor System | 1 | 2015 | 208 | 0.030 |
Why?
|
| Informed Consent | 1 | 2021 | 1010 | 0.030 |
Why?
|
| Photic Stimulation | 2 | 2012 | 1997 | 0.030 |
Why?
|
| Ethylene Glycols | 1 | 2016 | 198 | 0.030 |
Why?
|
| Heart Rate | 1 | 2006 | 4214 | 0.030 |
Why?
|
| Gene Expression | 1 | 2007 | 7598 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2016 | 387 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 2253 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2008 | 18349 | 0.030 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2018 | 702 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2020 | 1613 | 0.030 |
Why?
|
| Nortriptyline | 1 | 2014 | 79 | 0.030 |
Why?
|
| Chile | 1 | 2015 | 258 | 0.030 |
Why?
|
| Personality Tests | 1 | 2014 | 80 | 0.030 |
Why?
|
| Circadian Rhythm | 2 | 2009 | 2593 | 0.030 |
Why?
|
| Amitriptyline | 1 | 2014 | 112 | 0.030 |
Why?
|
| Ovary | 1 | 2018 | 965 | 0.030 |
Why?
|
| Birth Injuries | 1 | 2015 | 151 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 859 | 0.030 |
Why?
|
| Body Weight | 3 | 2013 | 4627 | 0.030 |
Why?
|
| Positron-Emission Tomography | 2 | 2024 | 6669 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2019 | 1334 | 0.030 |
Why?
|
| Putamen | 1 | 2015 | 291 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 1997 | 1587 | 0.030 |
Why?
|
| Caudate Nucleus | 1 | 2015 | 391 | 0.030 |
Why?
|
| Judgment | 1 | 2015 | 273 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 474 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 2202 | 0.030 |
Why?
|
| Secondary Prevention | 2 | 2010 | 1474 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2001 | 1862 | 0.030 |
Why?
|
| England | 1 | 2014 | 533 | 0.030 |
Why?
|
| Placebos | 1 | 1997 | 1667 | 0.030 |
Why?
|
| Acupuncture Points | 1 | 2013 | 111 | 0.030 |
Why?
|
| Professional-Patient Relations | 1 | 1998 | 724 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2016 | 680 | 0.030 |
Why?
|
| Peptide Fragments | 2 | 2018 | 5151 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2020 | 2937 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 2005 | 2517 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2018 | 1149 | 0.030 |
Why?
|
| Saccades | 1 | 2014 | 235 | 0.030 |
Why?
|
| Michigan | 1 | 2013 | 330 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2015 | 353 | 0.030 |
Why?
|
| Sensory Gating | 1 | 2012 | 47 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2020 | 1965 | 0.030 |
Why?
|
| Sweden | 1 | 2015 | 1382 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 1625 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 22379 | 0.030 |
Why?
|
| Carbonic Anhydrases | 1 | 1993 | 108 | 0.030 |
Why?
|
| Reduced Folate Carrier Protein | 1 | 2011 | 9 | 0.020 |
Why?
|
| Survivors | 1 | 2023 | 2381 | 0.020 |
Why?
|
| Ferredoxin-NADP Reductase | 1 | 2011 | 12 | 0.020 |
Why?
|
| Internship and Residency | 1 | 1992 | 5953 | 0.020 |
Why?
|
| Fornix, Brain | 1 | 2012 | 71 | 0.020 |
Why?
|
| Leukocytes | 1 | 2020 | 2035 | 0.020 |
Why?
|
| Anticipation, Psychological | 1 | 2012 | 91 | 0.020 |
Why?
|
| Estonia | 1 | 2011 | 56 | 0.020 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2011 | 28 | 0.020 |
Why?
|
| Classification | 1 | 2012 | 128 | 0.020 |
Why?
|
| Mothers | 1 | 2022 | 2209 | 0.020 |
Why?
|
| Forecasting | 1 | 2021 | 2945 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1993 | 766 | 0.020 |
Why?
|
| Social Perception | 1 | 2015 | 434 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 1074 | 0.020 |
Why?
|
| Income | 1 | 2020 | 1878 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2014 | 753 | 0.020 |
Why?
|
| RNA Interference | 1 | 2020 | 2832 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 1752 | 0.020 |
Why?
|
| Caffeine | 1 | 2016 | 703 | 0.020 |
Why?
|
| Long-Term Care | 1 | 1995 | 631 | 0.020 |
Why?
|
| Baltimore | 1 | 2011 | 233 | 0.020 |
Why?
|
| Inpatients | 1 | 2023 | 2566 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 2012 | 5315 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2016 | 1194 | 0.020 |
Why?
|
| Interviews as Topic | 2 | 2008 | 2741 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 3428 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2013 | 1001 | 0.020 |
Why?
|
| History, 17th Century | 1 | 1991 | 108 | 0.020 |
Why?
|
| Medial Forebrain Bundle | 1 | 2010 | 42 | 0.020 |
Why?
|
| Internal Medicine | 1 | 1998 | 1064 | 0.020 |
Why?
|
| China | 1 | 2017 | 2395 | 0.020 |
Why?
|
| Aniline Compounds | 1 | 2016 | 1094 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 23645 | 0.020 |
Why?
|
| Nuclear Proteins | 2 | 2017 | 5804 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2011 | 247 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2014 | 498 | 0.020 |
Why?
|
| History, 18th Century | 1 | 1991 | 206 | 0.020 |
Why?
|
| Public Health | 1 | 2023 | 2679 | 0.020 |
Why?
|
| Skull | 1 | 2015 | 820 | 0.020 |
Why?
|
| Forearm | 1 | 2012 | 427 | 0.020 |
Why?
|
| Finland | 1 | 2011 | 609 | 0.020 |
Why?
|
| Gait | 1 | 2015 | 823 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2013 | 371 | 0.020 |
Why?
|
| Magnetoencephalography | 1 | 2014 | 641 | 0.020 |
Why?
|
| Reaction Time | 1 | 2016 | 2101 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2023 | 3479 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2011 | 418 | 0.020 |
Why?
|
| Italy | 1 | 2011 | 856 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 1997 | 4860 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2013 | 935 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2021 | 1907 | 0.020 |
Why?
|
| Pain Threshold | 1 | 2013 | 607 | 0.020 |
Why?
|
| Acetaminophen | 1 | 2013 | 552 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2011 | 534 | 0.020 |
Why?
|
| Minisatellite Repeats | 1 | 2009 | 162 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2016 | 1200 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2017 | 1628 | 0.020 |
Why?
|
| Rest | 1 | 2014 | 948 | 0.020 |
Why?
|
| Chi-Square Distribution | 2 | 2008 | 3436 | 0.020 |
Why?
|
| Confidentiality | 1 | 2013 | 607 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2003 | 12800 | 0.020 |
Why?
|
| Delivery, Obstetric | 1 | 2015 | 954 | 0.020 |
Why?
|
| Auditory Perceptual Disorders | 1 | 2008 | 36 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3589 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2009 | 378 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2010 | 781 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2012 | 1419 | 0.020 |
Why?
|
| Australia | 1 | 2011 | 1265 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2012 | 1255 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1992 | 2230 | 0.020 |
Why?
|
| Child Abuse, Sexual | 1 | 2010 | 400 | 0.020 |
Why?
|
| Hostility | 1 | 2008 | 185 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2016 | 1168 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 5797 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1999 | 10760 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2011 | 801 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 2008 | 623 | 0.020 |
Why?
|
| Body Height | 1 | 2013 | 1565 | 0.020 |
Why?
|
| Psychometrics | 1 | 2016 | 3063 | 0.020 |
Why?
|
| Netherlands | 1 | 2011 | 2277 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2015 | 2227 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 515 | 0.020 |
Why?
|
| Vagotomy | 1 | 1986 | 83 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2012 | 952 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 3837 | 0.020 |
Why?
|
| Bezoars | 1 | 1986 | 29 | 0.020 |
Why?
|
| Marketing | 1 | 2008 | 224 | 0.020 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2006 | 300 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2006 | 285 | 0.020 |
Why?
|
| Food | 1 | 2010 | 768 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2020 | 4543 | 0.020 |
Why?
|
| Aggression | 1 | 2010 | 750 | 0.020 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2005 | 74 | 0.020 |
Why?
|
| Immobilization | 1 | 1986 | 229 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6229 | 0.010 |
Why?
|
| Principal Component Analysis | 1 | 2008 | 948 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3603 | 0.010 |
Why?
|
| Models, Biological | 1 | 2021 | 9495 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2017 | 3445 | 0.010 |
Why?
|
| Orthognathic Surgical Procedures | 1 | 1986 | 120 | 0.010 |
Why?
|
| Biometry | 1 | 2007 | 570 | 0.010 |
Why?
|
| Medical History Taking | 1 | 2008 | 779 | 0.010 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2015 | 1481 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1995 | 8542 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 13014 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3610 | 0.010 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2005 | 277 | 0.010 |
Why?
|
| Social Adjustment | 1 | 1986 | 635 | 0.010 |
Why?
|
| Premature Birth | 1 | 2015 | 1829 | 0.010 |
Why?
|
| Behavior, Addictive | 1 | 2008 | 428 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2009 | 1443 | 0.010 |
Why?
|
| Menopause | 1 | 2011 | 1656 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2013 | 3228 | 0.010 |
Why?
|
| Conflict of Interest | 1 | 2008 | 556 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 6316 | 0.010 |
Why?
|
| Checklist | 1 | 2010 | 840 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 2008 | 785 | 0.010 |
Why?
|
| Violence | 1 | 2009 | 936 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 3533 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 15454 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2007 | 2278 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2005 | 471 | 0.010 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2009 | 1741 | 0.010 |
Why?
|
| Choice Behavior | 1 | 2008 | 848 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 3445 | 0.010 |
Why?
|
| Clozapine | 1 | 2005 | 509 | 0.010 |
Why?
|
| Age Distribution | 1 | 2007 | 2873 | 0.010 |
Why?
|
| Markov Chains | 1 | 2005 | 979 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 4352 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2006 | 1695 | 0.010 |
Why?
|
| Memory, Short-Term | 1 | 2008 | 1008 | 0.010 |
Why?
|
| Crime Victims | 1 | 2005 | 347 | 0.010 |
Why?
|
| Base Sequence | 2 | 2007 | 12421 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 3858 | 0.010 |
Why?
|
| Body Image | 1 | 1986 | 646 | 0.010 |
Why?
|
| Anxiety, Separation | 1 | 2001 | 85 | 0.010 |
Why?
|
| Exons | 1 | 2007 | 2394 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 1993 | 3329 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2013 | 2295 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 20760 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6082 | 0.010 |
Why?
|
| Thiazoles | 1 | 2008 | 1542 | 0.010 |
Why?
|
| Mitochondria | 1 | 2014 | 3681 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 1892 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2013 | 3986 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8741 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3800 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6526 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9523 | 0.010 |
Why?
|
| Insulin | 1 | 2013 | 6607 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2013 | 6430 | 0.010 |
Why?
|
| Life Expectancy | 1 | 2005 | 1248 | 0.010 |
Why?
|
| Piperazines | 1 | 2008 | 2554 | 0.010 |
Why?
|
| Oxygen | 1 | 2008 | 4270 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 8128 | 0.010 |
Why?
|
| Sexual Behavior | 1 | 1986 | 2197 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 3706 | 0.010 |
Why?
|
| Burns | 1 | 2007 | 1899 | 0.010 |
Why?
|
| Patient Selection | 1 | 2008 | 4260 | 0.010 |
Why?
|
| Quality of Life | 2 | 2009 | 13490 | 0.010 |
Why?
|
| Causality | 1 | 2001 | 1254 | 0.010 |
Why?
|
| Rats, Inbred BN | 1 | 1995 | 231 | 0.010 |
Why?
|
| Heterozygote | 1 | 2001 | 2798 | 0.010 |
Why?
|
| Boston | 1 | 2007 | 9374 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 1986 | 3205 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2001 | 8054 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 17622 | 0.000 |
Why?
|